Non-clinical immuno-toxicological evaluation of HER1 cancer vaccine in non-human primates: a 12-month study-Reference-Cited by-同舟云学术

Non-clinical immuno-toxicological evaluation of HER1 cancer vaccine in non-human primates: a 12-month study

Published:2012-12 Issue:1 Volume:31 Page:89-95
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Barro Ana M. Bada,Rivero Arianna Iglesias,Goñi Avelina León,Navarro Bárbara O. González,Angarica Meilis Mesa,Ramírez Belinda Sánchez,Bedoya Darel Martínez,Triana Consuelo González,Rodríguez Axel Mancebo,Parada Ángel Casacó

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference37 articles.

1. World Health Organization (WHO). The global burden of disease: 2004 update. Geneva: World Health Organization; 2008.

2. Limited impact of palliative chemotherapy on survival in advanced solid tumours in patients with poor performance status;Sánchez-Muñoz;Clin Transl Oncol,2011

3. Tumor immunosurveillance in human cancers;Mlecnik;Cancer Metastasis Rev,2011

4. Principles of tumor immunosurveillance and implications for immunotherapy;Ochsenbein;Cancer Gene Ther,2002

5. Immunotherapy of malignant diseases. Challenges and strategies;Ko;Int Arch Allergy Immunol,2003

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polyclonal antibody-induced downregulation of HER1/EGFR and HER2 surpasses the effect of combinations of specific registered antibodies;Frontiers in Oncology;2022-11-02

2. Immuno-toxicological evaluation of her1 cancer vaccine in non-human primates: a 6-month subcutaneous study;Immunopharmacology and Immunotoxicology;2021-03-16

3. HER1-based vaccine: Simultaneous activation of humoral and cellular immune response;Seminars in Oncology;2018-01

4. Anti-proliferative and pro-apoptotic effects induced by simultaneous inactivation of HER1 and HER2 through endogenous polyclonal antibodies;Oncotarget;2017-08-03

5. Safety and Immunogenicity of a Human Epidermal Growth Factor Receptor 1 (HER1)-Based Vaccine in Prostate Castration-Resistant Carcinoma Patients: A Dose-Escalation Phase I Study Trial;Frontiers in Pharmacology;2017